• Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Profit News Report
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Profit News Report
No Result
View All Result
Home Investing

Nvidia stock in the green after China chip approval reports: can it keep going higher?

by
January 29, 2026
in Investing
0
Nvidia stock in the green after China chip approval reports: can it keep going higher?
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Nvidia stock rose early on Wednesday as investors welcomed signs of progress in the company’s access to the Chinese market, easing a key overhang that has weighed on the stock for months.

Optimism around continued funding momentum for artificial intelligence development, including potential capital backing for ChatGPT-developer OpenAI, also supported sentiment toward the chipmaker.

Nvidia shares were up 1.6% at $191.81 in early trading, pushing the stock toward the upper end of a range between roughly $170 and $190, where it has largely traded since early November.

The move raised expectations that the stock could break out of that range if positive news flows around China and AI spending continues.

China clears first H200 imports

The rally followed a Reuters report that China has approved its first imports of Nvidia’s H200 artificial-intelligence chips, marking a notable shift after months of regulatory uncertainty and tight scrutiny of advanced US-made hardware.

According to the report, which cited people familiar with the matter, Chinese authorities granted clearance for several hundred thousand H200 chips during a visit to China this week by Nvidia Chief Executive Officer Jensen Huang.

The approvals were said to be concentrated among three large Chinese internet companies, with additional firms lining up for later batches.

The move suggests that Beijing is balancing its push to develop domestic AI capabilities with the immediate need for advanced computing power to support data centres and large-scale artificial intelligence projects.

Easing stance reflects near-term AI needs

The decision represents a meaningful easing after months of mixed signals from Chinese regulators, who have repeatedly emphasised self-reliance in semiconductors while also grappling with the practical constraints facing domestic developers.

Chinese AI companies have faced growing bottlenecks in training and deploying large models due to limited access to high-performance chips.

Nvidia’s H200 is widely viewed as the most powerful AI processor China can realistically obtain under current US export restrictions.

According to the Institute for Progress think tank, the H200 offers roughly a 32% processing-power advantage over Huawei’s Ascend 910C, currently the most advanced domestically produced AI chip.

That performance gap has made Nvidia’s hardware highly sought after by Chinese developers racing to keep pace with global advances in artificial intelligence.

Range-bound trading may be ending

Nvidia stock has been range-bound for several months, as investors weighed strong global AI demand against geopolitical and regulatory risks tied to China.

The lack of sustained progress on Chinese sales has been a key reason the shares struggled to push meaningfully higher, even as Nvidia continued to report strong results elsewhere.

Wednesday’s news provided one of the clearest indications yet that the China issue may be moving toward resolution, at least partially.

That has prompted some investors to reassess the stock’s near-term trajectory.

With shares now approaching the top of their recent trading range, a confirmed pickup in Chinese shipments could serve as a catalyst for further gains, particularly if it coincides with continued investment in AI platforms globally.

The post Nvidia stock in the green after China chip approval reports: can it keep going higher? appeared first on Invezz

Previous Post

Europe bulletin: Starmer courts China, ASML surges on AI, Germany’s growth stalls

Next Post

Palladyne stock: 3 big reasons to sell it on Air Force contract rally

Next Post
Palladyne stock: 3 big reasons to sell it on Air Force contract rally

Palladyne stock: 3 big reasons to sell it on Air Force contract rally

  • Trending
  • Comments
  • Latest
Trump’s Fed Criticism Sparks Investor Concerns

Trump’s Fed Criticism Sparks Investor Concerns

April 22, 2025
A look back at Biden’s Remarkable 50-year career in politics

A look back at Biden’s Remarkable 50-year career in politics

March 20, 2025
Fed’s Stagflation Warning Impacts Crypto Markets

Fed’s Stagflation Warning Impacts Crypto Markets

April 21, 2025
Spire Healthcare shares surge 20% after confirming talks with buyout firms

Spire Healthcare shares surge 20% after confirming talks with buyout firms

January 27, 2026
US futures steady as retail sales, jobs and CPI data take center stage

US futures steady as retail sales, jobs and CPI data take center stage

0
Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

0
The dollar index continues to pull back to a new low

The dollar index continues to pull back to a new low

0
BNGO Stock: BioNano Genomics Analysis and Forecast

BNGO Stock: BioNano Genomics Analysis and Forecast

0
US futures steady as retail sales, jobs and CPI data take center stage

US futures steady as retail sales, jobs and CPI data take center stage

February 11, 2026
Coca-Cola stock slumps as Q4 revenue misses estimates

Coca-Cola stock slumps as Q4 revenue misses estimates

February 11, 2026
CVS Health beats expectations as turnaround strategy gains traction

CVS Health beats expectations as turnaround strategy gains traction

February 11, 2026
US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH

US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH

February 11, 2026

Recent News

US futures steady as retail sales, jobs and CPI data take center stage

US futures steady as retail sales, jobs and CPI data take center stage

February 11, 2026
Coca-Cola stock slumps as Q4 revenue misses estimates

Coca-Cola stock slumps as Q4 revenue misses estimates

February 11, 2026
CVS Health beats expectations as turnaround strategy gains traction

CVS Health beats expectations as turnaround strategy gains traction

February 11, 2026
US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH

US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH

February 11, 2026
  • Privacy Policy
  • Terms & Conditions
  • Privacy Policy
  • Terms & Conditions

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com

No Result
View All Result
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com